| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Use of vancomycin or first-generation cephalosporins for the treatment of hemodialysis-dependent patients with methicillin-susceptible Staphylococcus aureus bacteremia.
|
Clin Infect Dis
|
2006
|
3.70
|
|
2
|
Guidelines for the management of chronic kidney disease in HIV-infected patients: recommendations of the HIV Medicine Association of the Infectious Diseases Society of America.
|
Clin Infect Dis
|
2005
|
3.63
|
|
3
|
Death or hospitalization of patients on chronic hemodialysis is associated with a physician-based diagnosis of depression.
|
Kidney Int
|
2008
|
3.34
|
|
4
|
Association between pulse pressure and mortality in patients undergoing maintenance hemodialysis.
|
JAMA
|
2002
|
2.98
|
|
5
|
Impact of renal dysfunction on outcomes of coronary artery bypass surgery: results from the Society of Thoracic Surgeons National Adult Cardiac Database.
|
Circulation
|
2006
|
2.51
|
|
6
|
Individual patient- versus group-level data meta-regressions for the investigation of treatment effect modifiers: ecological bias rears its ugly head.
|
Stat Med
|
2002
|
2.49
|
|
7
|
Development of proteinuria or elevated serum creatinine and mortality in HIV-infected women.
|
J Acquir Immune Defic Syndr
|
2003
|
2.11
|
|
8
|
Highly active antiretroviral therapy and the epidemic of HIV+ end-stage renal disease.
|
J Am Soc Nephrol
|
2005
|
1.94
|
|
9
|
Trends in anemia management among US hemodialysis patients.
|
J Am Soc Nephrol
|
2002
|
1.92
|
|
10
|
Cystatin C, albuminuria, and 5-year all-cause mortality in HIV-infected persons.
|
Am J Kidney Dis
|
2010
|
1.84
|
|
11
|
Costs and outcomes among hemodialysis-dependent patients with methicillin-resistant or methicillin-susceptible Staphylococcus aureus bacteremia.
|
Infect Control Hosp Epidemiol
|
2005
|
1.69
|
|
12
|
Characteristics of treated hypertension in incident hemodialysis and peritoneal dialysis patients.
|
Am J Kidney Dis
|
2003
|
1.60
|
|
13
|
Medical costs of abnormal serum sodium levels.
|
J Am Soc Nephrol
|
2008
|
1.56
|
|
14
|
Suppression of HIV-1 replication by antiretroviral therapy improves renal function in persons with low CD4 cell counts and chronic kidney disease.
|
AIDS
|
2008
|
1.46
|
|
15
|
Restless legs syndrome reported by incident haemodialysis patients: is treatment time of day relevant?
|
Nephrology (Carlton)
|
2012
|
1.42
|
|
16
|
Incidence and etiology of acute renal failure among ambulatory HIV-infected patients.
|
Kidney Int
|
2005
|
1.40
|
|
17
|
Association of blood pressure increases during hemodialysis with 2-year mortality in incident hemodialysis patients: a secondary analysis of the Dialysis Morbidity and Mortality Wave 2 Study.
|
Am J Kidney Dis
|
2009
|
1.39
|
|
18
|
Clinical outcomes and costs due to Staphylococcus aureus bacteremia among patients receiving long-term hemodialysis.
|
Infect Control Hosp Epidemiol
|
2005
|
1.38
|
|
19
|
Does calcium kill ESRD patients--the skeptic's perspective.
|
Nephrol Dial Transplant
|
2002
|
1.37
|
|
20
|
Relationship between interdialytic weight gain and blood pressure among prevalent hemodialysis patients.
|
Am J Kidney Dis
|
2007
|
1.32
|
|
21
|
Cockcroft-Gault versus modification of diet in renal disease: importance of glomerular filtration rate formula for classification of chronic kidney disease in patients with non-ST-segment elevation acute coronary syndromes.
|
J Am Coll Cardiol
|
2008
|
1.30
|
|
22
|
Physician-diagnosed depression as a correlate of hospitalizations in patients receiving long-term hemodialysis.
|
Am J Kidney Dis
|
2005
|
1.27
|
|
23
|
Chronic kidney disease in patients with non-ST-segment elevation acute coronary syndromes.
|
Am J Med
|
2006
|
1.24
|
|
24
|
Rates and risk factors for condition-specific hospitalizations in HIV-infected and uninfected women.
|
J Acquir Immune Defic Syndr
|
2003
|
1.20
|
|
25
|
The impact of kidney function at highly active antiretroviral therapy initiation on mortality in HIV-infected women.
|
J Acquir Immune Defic Syndr
|
2010
|
1.15
|
|
26
|
Immunosuppression, hepatitis C infection, and acute renal failure in HIV-infected patients.
|
J Acquir Immune Defic Syndr
|
2006
|
1.12
|
|
27
|
White blood cells as a novel mortality predictor in haemodialysis patients.
|
Nephrol Dial Transplant
|
2003
|
1.12
|
|
28
|
The efficacy and safety of short- and long-term dual antiplatelet therapy in patients with mild or moderate chronic kidney disease: results from the Clopidogrel for the Reduction of Events During Observation (CREDO) trial.
|
Am Heart J
|
2008
|
1.10
|
|
29
|
The association between depression and chronic kidney disease and mortality among patients hospitalized with congestive heart failure.
|
Am J Kidney Dis
|
2004
|
1.06
|
|
30
|
The effects of HIV type-1 viral suppression and non-viral factors on quantitative proteinuria in the highly active antiretroviral therapy era.
|
Antivir Ther
|
2009
|
1.02
|
|
31
|
Mortality by dialysis modality among patients who have end-stage renal disease and are awaiting renal transplantation.
|
Clin J Am Soc Nephrol
|
2006
|
1.01
|
|
32
|
Sensitivity of International Classification of Diseases codes for hyponatremia among commercially insured outpatients in the United States.
|
BMC Nephrol
|
2008
|
1.01
|
|
33
|
Cardiovascular disease and chronic kidney disease: insights and an update.
|
Am Heart J
|
2004
|
1.00
|
|
34
|
World Kidney Day 2009: problems and challenges in the emerging epidemic of kidney disease.
|
J Am Soc Nephrol
|
2009
|
1.00
|
|
35
|
Proteinuria, creatinine clearance, and immune activation in antiretroviral-naive HIV-infected subjects.
|
J Infect Dis
|
2009
|
1.00
|
|
36
|
The pharmacokinetics and pharmacogenomics of efavirenz and lopinavir/ritonavir in HIV-infected persons requiring hemodialysis.
|
AIDS
|
2008
|
0.99
|
|
37
|
Do income level and race influence survival in patients receiving hemodialysis?
|
Am J Med
|
2009
|
0.98
|
|
38
|
Decreased pulse pressure during hemodialysis is associated with improved 6-month outcomes.
|
Kidney Int
|
2009
|
0.90
|
|
39
|
Perioperative outcomes among patients with end-stage renal disease following coronary artery bypass surgery in the USA.
|
Nephrol Dial Transplant
|
2010
|
0.90
|
|
40
|
Relationship between clinical outcomes and vascular access type among hemodialysis patients with Staphylococcus aureus bacteremia.
|
Clin J Am Soc Nephrol
|
2006
|
0.90
|
|
41
|
Acute kidney injury in HIV-infected patients.
|
Semin Nephrol
|
2008
|
0.89
|
|
42
|
Cardiovascular toxicity of epoetin-alfa in patients with chronic kidney disease.
|
Am J Nephrol
|
2013
|
0.88
|
|
43
|
Leptin and renal disease.
|
Semin Dial
|
2006
|
0.87
|
|
44
|
Mortality, kidney disease and cardiac procedures following acute coronary syndrome.
|
Nephrol Dial Transplant
|
2007
|
0.87
|
|
45
|
Association between high-dose erythropoiesis-stimulating agents, inflammatory biomarkers, and soluble erythropoietin receptors.
|
BMC Nephrol
|
2011
|
0.85
|
|
46
|
Negative trials in nephrology: what can we learn?
|
Kidney Int
|
2008
|
0.84
|
|
47
|
Highly active antiretroviral therapy reduces urinary albumin excretion in women with HIV infection.
|
J Acquir Immune Defic Syndr
|
2008
|
0.82
|
|
48
|
Veterans more likely to start hemodialysis with an arteriovenous fistula.
|
Semin Dial
|
2011
|
0.81
|
|
49
|
Effect of hemoglobin target on progression of kidney disease: a secondary analysis of the CHOIR (Correction of Hemoglobin and Outcomes in Renal Insufficiency) trial.
|
Am J Kidney Dis
|
2012
|
0.81
|
|
50
|
Healthcare system interventions for inequality in quality: corrective action through evidence-based medicine.
|
J Natl Med Assoc
|
2002
|
0.81
|
|
51
|
Feast and famine: epidemiology and clinical trials in chronic kidney disease.
|
J Am Soc Nephrol
|
2007
|
0.80
|
|
52
|
Risk for cardiovascular outcomes among subjects with atherosclerotic cardiovascular disease and greater-than-normal estimated glomerular filtration rate.
|
Clin J Am Soc Nephrol
|
2007
|
0.80
|
|
53
|
What is the nephrologist's role as a primary care provider? We all have different answers.
|
Clin J Am Soc Nephrol
|
2007
|
0.80
|
|
54
|
Re-evaluating the volume-outcome relationship in hemodialysis patients.
|
Health Policy
|
2008
|
0.79
|
|
55
|
Management of HIV-infected patients with ESRD.
|
Adv Chronic Kidney Dis
|
2010
|
0.78
|
|
56
|
Hypothesis: an erythropoietin honeymoon phase exists.
|
Kidney Int
|
2010
|
0.77
|
|
57
|
Assessing the economic attractiveness of coronary artery revascularization in chronic kidney disease patients.
|
J Med Syst
|
2009
|
0.77
|
|
58
|
Patient and caregiver knowledge and utilization of partial versus radical nephrectomy: results of a national kidney foundation survey to assess educational needs of kidney cancer patients and caregivers.
|
Am J Kidney Dis
|
2013
|
0.77
|
|
59
|
Hemoglobin normalization studies.
|
Perit Dial Int
|
2007
|
0.77
|
|
60
|
Renal insufficiency and the risk of cardiovascular mortality.
|
Kidney Int
|
2002
|
0.77
|
|
61
|
Triumph and tragedy: anemia management in chronic kidney disease.
|
Curr Opin Nephrol Hypertens
|
2008
|
0.76
|
|
62
|
Prognostic value of troponins in patients with non-ST-segment elevation acute coronary syndromes and chronic kidney disease.
|
Clin Cardiol
|
2008
|
0.76
|
|
63
|
Hemodialysis does not significantly affect the pharmacokinetics of nevirapine in HIV-1-infected persons requiring hemodialysis: results from ACTG A5177.
|
J Acquir Immune Defic Syndr
|
2010
|
0.76
|
|
64
|
Steady-state pharmacokinetics of lamivudine in human immunodeficiency virus-infected patients with end-stage renal disease receiving chronic dialysis.
|
Antimicrob Agents Chemother
|
2002
|
0.75
|
|
65
|
Did 'renalism' skew the results of a negative study?
|
Nat Rev Nephrol
|
2010
|
0.75
|
|
66
|
HIV through a nephrologist's lens.
|
Adv Chronic Kidney Dis
|
2010
|
0.75
|
|
67
|
A decade after the KDOQI CKD guidelines: impact on the National Kidney Foundation.
|
Am J Kidney Dis
|
2012
|
0.75
|
|
68
|
Phosphate binders in chronic kidney disease and end-stage renal disease: a patient-centered approach.
|
Semin Dial
|
2008
|
0.75
|
|
69
|
Anemia management in chronic kidney disease.
|
Hemodial Int
|
2007
|
0.75
|
|
70
|
World Kidney Day 2008: think globally, speak locally.
|
J Am Soc Nephrol
|
2008
|
0.75
|
|
71
|
Anticoagulation in acute cardiac care in patients with chronic kidney disease.
|
Am Heart J
|
2003
|
0.75
|
|
72
|
A multi-dose pharmacokinetic study of dalteparin in haemodialysis patients.
|
Thromb Haemost
|
2006
|
0.75
|